Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (1080)	7/19/1999 10:01:00 PM
From: LLCF	Read Replies (1) \| Respond to of 3202

Wow, thanks for the great post... I'll have to continue back on the AFFX thread and see what those cats think. Thought this part was worth repeating: <Orchid and SmithKline Beecham (Philadelphia, PA) are collaborating on an instrument for combinatorial chemistry and bioactivity screening with the goal of producing a single device that can synthesize 10,000 different molecules. Incyte (Palo Alto, CA) joined with with Affymetrix to develop a database of functionally relevant genes. Hyseq joined with Perkin-Elmer/Applied Biosystems (Foster City, CA) in a strategic partnership to make a universal chip system that uses specially designed reagents and software to assay any genetic target. Nanogen and Becton Dickenson (Franklin Lakes, NJ) formed a venture to develop clinical diagnostic systems for infectious disease testing. Article describes these and other ventures in more detail, and also other new technologies.> especially this: <Hyseq joined with Perkin-Elmer/Applied Biosystems (Foster City, CA) in a strategic partnership to make a universal chip system that uses specially designed reagents and software to assay any genetic target.> What's the chances that THEY make the universal chip system... yea for their chips!! Interesting that INCY isn't listed as using the HP... wonder whose machine they use?? I'll call and ask. All this is very early, but will eventually be very important in the explosion of the biochip market IMO... there has to be a standard so people can order chips from all the players... once this happends the market could really rocket [hopfully]. INCY told me they have no interest in the hardware [good sign].... but that there is a lot of value added between the databases and chips working together. Since INCY is the database king with a dominant market share they could really put the screws to the other chip makers if this is true. This angle is probably why they have the bioinformatics division as such an important mention going forward??? Investor relations didn't want to speculate on the current or future "biotchip" market... any takers? DAK